Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.54 |
| ▸ | TDO2 | P48775 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | CNR2 | P34972 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | HTR1A | P08908 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL477349 | 1.00 | IDO1 (0.54) | IDO1TDO2HPGDSLC6A2SLC6A4 | |
| SCHEMBL477552 | 1.00 | IDO1 (0.54) | IDO1TDO2HPGDSLC6A2SLC6A4 | |
| SCHEMBL10439949 | 0.98 | IDO1 (0.52) | IDO1TDO2HPGDSLC6A2SLC6A4 | |
| SCHEMBL1426754 | 0.89 | TSHR (0.50) | IDO1TDO2HPGDTSHR | |
| Diphenylmethanol SCHEMBL11366184 | 0.89 | MEN1 (0.45) | IDO1TDO2HPGDSLC6A2SLC6A4 | |
| SCHEMBL6075135 | 0.89 | CYP1A2 (0.65) | IDO1TDO2HPGDCNR2CYP1A2 | |
| SCHEMBL8671295 | 0.87 | SMN1; SMN2 (0.58) | SMN1; SMN2TSHRCA12CA1CA2 | |
| SCHEMBL6874895 | 0.85 | SLC6A2 (0.59) | IDO1TDO2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL5161936 | 0.84 | SRD5A2 (0.55) | HPGDSMN1; SMN2TSHRMEN1KMT2A | |
| Diphenylmethanol SCHEMBL10868602 | 0.84 | SMN1; SMN2 (0.61) | SMN1; SMN2TSHRCA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 251 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115598261-B | Method for measuring related substances in raw material and preparation of clopidodine hydrochloride | 地奥集团成都药业股份有限公司 | 2024-10-29 | — | — | CN | claimed |
| CN-118791343-A | Alpha-alkylation method of ketone | 复旦大学 | 2024-10-18 | — | — | CN | claimed |
| CN-112517060-B | Catalyst, application and synthesis method of 4-hydroxycoumarin derivative | 山东农业大学 | 2022-03-25 | — | — | CN | claimed |
| CN-113387799-B | Preparation method of gamma, gamma-diaryl ester or gamma, gamma-triaryl ester compound and product thereof | 南京工业大学 | 2021-12-21 | — | — | CN | claimed |
| CN-113387799-A | Preparation method of gamma, gamma-diaryl ester or gamma, gamma-triaryl ester compound and product thereof | 南京工业大学 | 2021-09-14 | — | — | CN | claimed |
| CN-107790186-B | Novel decamethyl cyclopentadienyl zirconium complex and preparation method and application thereof | 山西医科大学 | 2020-10-30 | — | — | CN | claimed |
| CN-108084049-B | Preparation method of posaconazole intermediate | 重庆圣华曦药业股份有限公司 | 2020-09-25 | — | — | CN | claimed |
| CN-102351675-A | Preparation process of 4-chlorophenyl benzyl ketone | UNIV CHANGZHOU | 2012-02-15 | — | — | CN | claimed |
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| EP-0894794-A1 | Optical isomers of cloperastine | AESCULAPIUS FARMACEUTICI S.r.l. (IT) | 1999-02-03 | — | — | EP | claimed |
| EP-0677076-B1 | DIARYL CARBINOL METATHESIS CATALYSTS | SHELL OIL CO (US) | 1997-04-16 | — | — | EP | claimed |
| EP-0686635-A1 | Pyridylthiazolidinecarboxylic acid amide derivatives, their preparation and their therapeutic uses | Sankyo Company Limited (JP) | 1995-12-13 | — | — | EP | claimed |
| US-5470851-A | Antihistamine, anticoagulants | SANKYO COMPANY, LIMITED (JP) | 1995-11-28 | — | — | US | claimed |
| EP-0677076-A1 | DIARYL CARBINOL METATHESIS CATALYSTS. | SHELL OIL CO (US) | 1995-10-18 | — | — | EP | claimed |
| WO-1994015989-A1 | DIARYL CARBINOL METATHESIS CATALYSTS | SHELL OIL COMPANY (US) | 1994-07-21 | — | — | WO | claimed |
| US-5276118-A | Metal complex | SHELL OIL COMPANY (US) | 1994-01-04 | — | — | US | claimed |
| EP-0549364-A1 | Pyridylthiazolidinecarboxylic acid amide derivatives, their preparation and their therapeutic uses | Sankyo Company Limited (JP) | 1993-06-30 | — | — | EP | claimed |
| EP-0385491-A1 | Optically active isomer of cloperastine possessing antitussive activity, a process for its preparation and pharmaceutical compositions which contain it | MAGIS FARMACEUTICI S.p.A. (IT) | 1990-09-05 | — | — | EP | claimed |
| WO-2025058989-A1 | NOVEL COMPOUNDS FOR TREATING CANCER | MARSAL THERAPEUTICS, INC. (US) | 2025-03-20 | — | — | WO | disclosed |
| CN-118993872-A | Refining process of fendithiino tussah acid | 四川吉龙兴瑞药业有限公司 | 2024-11-22 | — | — | CN | disclosed |
| CN-118993828-A | Method for synthesizing alkane by deoxidizing alcohol | 温州医科大学 | 2024-11-22 | — | — | CN | disclosed |
| CN-118993871-A | Preparation process of fendithiino tussah acid | 四川吉龙兴瑞药业有限公司 | 2024-11-22 | — | — | CN | disclosed |
| CN-118791343-A | Alpha-alkylation method of ketone | 复旦大学 | 2024-10-18 | — | — | CN | disclosed |
| CN-117362162-A | Preparation method of carbonyl compound | 中国科学院大连化学物理研究所 | 2024-01-09 | — | — | CN | disclosed |
| CN-116715563-A | Method for synthesizing diphenyl methane compounds and diphenyl ketone compounds by catalyzing diphenyl methanol compounds through zeolite | 常州大学 | 2023-09-08 | — | — | CN | disclosed |
| CN-116082410-A | Bidentate pyrimidinyl triazole carbene palladium hydrated 3-pyridine sulfonate compound, and preparation method and application thereof | 江苏科技大学 | 2023-05-09 | — | — | CN | disclosed |
| CN-113848271-B | Method for detecting related substances in levocetirizine hydrochloride oral solution | 浙江核力欣健药业有限公司 | 2023-04-28 | — | — | CN | disclosed |
| WO-2023047107-A1 | ARYL OR HETEROARYL DERIVED COMPOUNDS FOR THE TREATMENTS OF MICROBIAL INFECTIONS | THE UNIVERSITY OF DURHAM (GB) | 2023-03-30 | — | — | WO | disclosed |
| CN-115677480-A | TiO for preparing acid by selectively oxidizing primary alcohol under mild condition 2 Method for NaBr photocatalysis system | 东南大学 | 2023-02-03 | — | — | CN | disclosed |
| CN-115651014-A | Method for synthesizing diaryl phosphonate derivatives by acid catalysis | 西北民族大学 | 2023-01-31 | — | — | CN | disclosed |
| CN-111302913-B | Method for synthesizing polyaryl substituted aldehyde compound | 东华理工大学 | 2023-01-20 | — | — | CN | disclosed |
| CN-111269098-B | Method for synthesizing polyaryl substituted aldehyde compound by polyoxometalate catalytic dehydration coupling reaction | 东华理工大学 | 2023-01-20 | — | — | CN | disclosed |
| CN-114057561-B | Application of perfluorosulfonic acid resin in catalyzing reaction of benzyl alcohol compound and 1, 3-dicarbonyl compound | 上海应用技术大学 | 2022-12-16 | — | — | CN | disclosed |
| CN-111100851-B | Alcohol dehydrogenase mutant and application thereof in synthesis of chiral diaryl alcohol compound | 中国科学院天津工业生物技术研究所 | 2022-07-26 | — | — | CN | disclosed |
| US-20220226310-A1 | Bio-Based Medicines and Methods of Increasing Patient Compliance | RDE PHARMA | 2022-07-21 | — | — | US | disclosed |
| CN-114736098-A | Chloro compound and preparation method thereof | 上海泰坦科技股份有限公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-110726788-B | Method for separating and measuring levocetirizine hydrochloride and related substances thereof by high performance liquid chromatography | 湖南九典制药股份有限公司 | 2022-07-01 | — | — | CN | disclosed |
| CN-112517060-B | Catalyst, application and synthesis method of 4-hydroxycoumarin derivative | 山东农业大学 | 2022-03-25 | — | — | CN | disclosed |
| CN-114057561-A | Application of perfluorosulfonic acid resin in catalyzing reaction of benzyl alcohol compound and 1, 3-dicarbonyl compound | 上海应用技术大学 | 2022-02-18 | — | — | CN | disclosed |
| CN-113848271-A | Method for detecting related substances in levocetirizine hydrochloride oral solution | 浙江核力欣健药业有限公司 | 2021-12-28 | — | — | CN | disclosed |
| CN-113387799-B | Preparation method of gamma, gamma-diaryl ester or gamma, gamma-triaryl ester compound and product thereof | 南京工业大学 | 2021-12-21 | — | — | CN | disclosed |
| CN-113387799-A | Preparation method of gamma, gamma-diaryl ester or gamma, gamma-triaryl ester compound and product thereof | 南京工业大学 | 2021-09-14 | — | — | CN | disclosed |
| WO-2021093556-A1 | METHOD FOR PREPARING HYDROXYL COMPOUND, DEUTERATED COMPOUND THEREOF, AND TRITIATED COMPOUND THEREOF | 中国科学院福建物质结构研究所 | 2021-05-20 | — | — | WO | disclosed |
| EP-3801484-A1 | BIO-BASED MEDICINES AND METHODS OF INCREASING PATIENT COMPLIANCE | Anellotech, Inc. (US) | 2021-04-14 | — | — | EP | disclosed |
| CN-112517060-A | Catalyst, application and synthesis method of 4-hydroxycoumarin derivative | 山东农业大学 | 2021-03-19 | — | — | CN | disclosed |
| CN-109943543-B | Alcohol dehydrogenase mutant and preparation method and application thereof | 上海健康医学院 | 2020-12-11 | — | — | CN | disclosed |
| CN-109943543-B | Alcohol dehydrogenase mutant and preparation method and application thereof | 上海健康医学院 | 2020-12-11 | — | — | CN | disclosed |
| EP-3254860-B1 | RECORDING MATERIAL AND RECORDING SHEET | NIPPON SODA CO (JP) | 2020-11-04 | — | — | EP | disclosed |
| CN-107790186-B | Novel decamethyl cyclopentadienyl zirconium complex and preparation method and application thereof | 山西医科大学 | 2020-10-30 | — | — | CN | disclosed |
| CN-108084049-B | Preparation method of posaconazole intermediate | 重庆圣华曦药业股份有限公司 | 2020-09-25 | — | — | CN | disclosed |
| CN-111302913-A | Method for synthesizing polyaryl substituted aldehyde compound | 东华理工大学 | 2020-06-19 | — | — | CN | disclosed |
| CN-111269098-A | Method for synthesizing polyaryl substituted aldehyde compound by polyoxometalate catalytic dehydration coupling reaction | 东华理工大学 | 2020-06-12 | — | — | CN | disclosed |
| CN-111100851-A | Alcohol dehydrogenase mutant and application thereof in synthesis of chiral diaryl alcohol compound | 中国科学院天津工业生物技术研究所 | 2020-05-05 | — | — | CN | disclosed |
| CN-109053754-B | Synthetic method for constructing polysubstituted chroman compound based on biomass source 2, 5-dimethylfuran dearomatization cycloaddition strategy | 青岛农业大学 | 2020-04-07 | — | — | CN | disclosed |
| CN-110726788-A | Method for separating and measuring levocetirizine hydrochloride and related substances thereof by high performance liquid chromatography | 湖南九典制药股份有限公司 | 2020-01-24 | — | — | CN | disclosed |
| CN-110194724-A | A kind of compound containing diphenyl-methane structure and its application | 广州同隽医药科技有限公司 | 2019-09-03 | — | — | CN | disclosed |
| US-10369120-B2 | T type calcium channel inhibitors | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2019-08-06 | — | — | US | disclosed |
| US-10335775-B2 | Magnetically separable iron-based heterogeneous catalysts for dehydrogenation of alcohols and amines | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2019-07-02 | — | — | US | disclosed |
| US-10226957-B2 | Recording material and recording sheet | NIPPON SODA CO., LTD. (JP) | 2019-03-12 | — | — | US | disclosed |
| US-20180147568-A1 | MAGNETICALLY SEPARABLE IRON-BASED HETEROGENEOUS CATALYSTS FOR DEHYDROGENATION OF ALCOHOLS AND AMINES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2018-05-31 | — | — | US | disclosed |
| US-20180147568-A1 | MAGNETICALLY SEPARABLE IRON-BASED HETEROGENEOUS CATALYSTS FOR DEHYDROGENATION OF ALCOHOLS AND AMINES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2018-05-31 | — | — | US | disclosed |
| US-20180022137-A1 | RECORDING MATERIAL AND RECORDING SHEET | NIPPON SODA CO., LTD. (JP) | 2018-01-25 | — | — | US | disclosed |
| US-9828413-B2 | Vancomycin derivative, and preparation method and application thereof | ACESYS PHARMA INC. (CN) | 2017-11-28 | — | — | US | disclosed |
| US-9663476-B2 | Glycine transporter-1 inhibitors | AMGEN INC. (US) | 2017-05-30 | — | — | US | disclosed |
| CN-106518607-A | Method for preparing 4-chlorobenzhydrol | 枣阳凤泽精细化工有限公司 | 2017-03-22 | — | — | CN | disclosed |
| CN-106518607-A | Method for preparing 4-chlorobenzhydrol | 枣阳凤泽精细化工有限公司 | 2017-03-22 | — | — | CN | disclosed |
| CN-106397114-A | Preparation method of 4-chlorobenzhydrol | 枣阳凤泽精细化工有限公司 | 2017-02-15 | — | — | CN | disclosed |
| CN-106397114-A | Preparation method of 4-chlorobenzhydrol | 枣阳凤泽精细化工有限公司 | 2017-02-15 | — | — | CN | disclosed |
| WO-2016189553-A1 | MAGNETICALLY SEPARABLE IRON-BASED HETEROGENEOUS CATALYSTS FOR DEHYDROGENATION OF ALCOHOLS AND AMINES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-12-01 | — | — | WO | disclosed |
| US-20160200768-A1 | VANCOMYCIN DERIVATIVE, AND PREPARATION METHOD AND APPLICATION THEREOF | ACESYS PHARMA INC. (CN) | 2016-07-14 | — | — | US | disclosed |
| EP-3037431-A1 | VANCOMYCIN DERIVATIVE, AND PREPARATION METHOD AND APPLICATION THEREOF | Acesys Pharma Inc. (CN) | 2016-06-29 | — | — | EP | disclosed |
| US-20160136115-A1 | T TYPE CALCIUM CHANNEL INHIBITORS | UNIVERSITY OF VIRGINIA | 2016-05-19 | — | — | US | disclosed |
| CN-103073372-B | The method of functionalized ion liquid catalytically synthesizing aminated compounds | LANZHOU INSTITUTE OF CHEMICAL PHYSICS, CHINESE ACADEMY OF SCIENCES (CN) | 2016-03-02 | — | — | CN | disclosed |
| CN-104387237-B | Simulated moving bed chromatography separation divides the method for 4-chlorodiphenyl methyl alcohol enantiomorph | JIANGSU HANBON SCIENCE & TECHNOLOGY CO., LTD. (CN) | 2016-01-27 | — | — | CN | disclosed |
| US-9212127-B2 | T type calcium channel inhibitors | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2015-12-15 | — | — | US | disclosed |
| EP-2947067-A1 | Glycine transporter-1 inhibitors | Amgen, Inc (US) | 2015-11-25 | — | — | EP | disclosed |
| US-20150307457-A1 | GLYCINE TRANSPORTER-1 INHIBITORS | AMGEN INC. (US) | 2015-10-29 | — | — | US | disclosed |
| CN-104529943-A | Industrial preparation method of cloperastine | CHONGQING KANGLE PHARMACEUTICAL CO LTD | 2015-04-22 | — | — | CN | disclosed |
| CN-104387237-A | Resolution method of 4-chlorobenzhydrol enantiomer by simulated moving bed chromatography | JIANGSU HANBON SCI & TECH CO | 2015-03-04 | — | — | CN | disclosed |
| CN-104387237-A | Resolution method of 4-chlorobenzhydrol enantiomer by simulated moving bed chromatography | JIANGSU HANBON SCI & TECH CO | 2015-03-04 | — | — | CN | disclosed |
| CN-104387237-A | Resolution method of 4-chlorobenzhydrol enantiomer by simulated moving bed chromatography | JIANGSU HANBON SCI & TECH CO | 2015-03-04 | — | — | CN | disclosed |
| CN-104341327-A | Multi-halogen substituted 2-(diphenylmethyl sulfinyl)acetamide compounds and stereoisomers thereof | 63975 PLA TROOPS | 2015-02-11 | — | — | CN | disclosed |
| CN-104327014-A | Preparation method of levo cloperastine fendizoate | CHONGQING HENG AN CHEMICAL CO LTD | 2015-02-04 | — | — | CN | disclosed |
| CN-103896729-A | Method for preparing 4-dichlorodiphenylmethane | UNIV PEKING FOUNDER GROUP CO | 2014-07-02 | — | — | CN | disclosed |
| US-8735383-B2 | Glycine transporter-1 inhibitors | AMGEN INC. (US) | 2014-05-27 | — | — | US | disclosed |
| EP-2041088-B1 | GLYCINE TRANSPORTER-1 INHIBITORS | AMGEN INC (US) | 2014-01-08 | — | — | EP | disclosed |
| US-8563786-B2 | Method for producing optically active alcohol | MITSUI CHEMICALS, INC. (JP) | 2013-10-22 | — | — | US | disclosed |
| CN-103073372-A | Method for synthesizing amine compound catalyzed by functionalized ionic liquid | LANZHOU CHEM PHYS INST | 2013-05-01 | — | — | CN | disclosed |
| EP-2565183-A1 | Glycine transporter-1 inhibitors | Amgen Inc. (US) | 2013-03-06 | — | — | EP | disclosed |
| CN-101479243-B | Glycine transporter-1 inhibitors | AMGEN INC | 2013-01-02 | — | — | CN | disclosed |
| EP-1858644-B1 | METHOD FOR ASYMMETRIC HYDROSILYLATION OF KETONES | UNIV HONG KONG POLYTECHNIC (CN) | 2012-11-21 | — | — | EP | disclosed |
| US-20120264804-A1 | T TYPE CALCIUM CHANNEL BLOCKERS AND THE TREATMENT OF DISEASES | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2012-10-18 | — | — | US | disclosed |
| US-20120195985-A1 | GLYCINE TRANSPORTER-1 INHIBITORS | AMGEN INC. (US) | 2012-08-02 | — | — | US | disclosed |
| US-8183244-B2 | Glycine transporter-1 inhibitors | AMGEN INC. (US) | 2012-05-22 | — | — | US | disclosed |
| US-20120088938-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2012-04-12 | — | — | US | disclosed |
| CN-102351675-A | Preparation process of 4-chlorophenyl benzyl ketone | UNIV CHANGZHOU | 2012-02-15 | — | — | CN | disclosed |
| CN-102351675-A | Preparation process of 4-chlorophenyl benzyl ketone | UNIV CHANGZHOU | 2012-02-15 | — | — | CN | disclosed |
| EP-2412694-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | Mitsui Chemicals, Inc. (JP) | 2012-02-01 | — | — | EP | disclosed |
| US-20100222406-A1 | T Type Calcium Channel Blockers and the Treatment of Diseases | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2010-09-02 | — | — | US | disclosed |
| US-7718831-B2 | Chiral dipyridylphospine ligands bound to transition metal catalyst for catalysis of reactions under air atmosphere, normal atmosphere, mild temperatures without addition of organic or inorganic base; air-accelerated, copper(II) catalyzed asymmetric hydrosilylations reactions | THE HONG KONG POLYTECHNIC UNIVERSITY (HK) | 2010-05-18 | — | — | US | disclosed |
| US-7638628-B2 | for the reduction of ketones to alcohols via hydrogen transfer; reduction catalysts; hydrogenation catalysts | UNIVERSITA' DEGLI STUDI DI UDINE (IT) | 2009-12-29 | — | — | US | disclosed |
| US-7592487-B2 | Chiral tertiary aminoalkylnaphthols | THE HONG KONG POLYTECHNIC UNIVERSITY (HK) | 2009-09-22 | — | — | US | disclosed |
| US-20090234019-A1 | T Type Calcium Channel Inhibitors | UNIVERSITY OF VIRGINIA | 2009-09-17 | — | — | US | disclosed |
| US-20090227595-A1 | GLYCINE TRANSPORTER-1 INHIBITORS | HITCHCOCK STEPHEN | 2009-09-10 | — | — | US | disclosed |
| US-7569734-B2 | Method of using rhodium quinonoid catalysts | BROWN UNIVERSITY (US) | 2009-08-04 | — | — | US | disclosed |
| US-7563916-B2 | Process for producing an alcohol or a silyl ether thereof | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-07-21 | — | — | US | disclosed |
| US-7563916-B2 | Process for producing an alcohol or a silyl ether thereof | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-07-21 | — | — | US | disclosed |
| CN-101479243-A | Glycine transporter-1 inhibitors | AMGEN INC (US) | 2009-07-08 | — | — | CN | disclosed |
| US-7538114-B2 | Glycine transporter-1 inhibitors | AMGEN INC. (US) | 2009-05-26 | — | — | US | disclosed |
| EP-2041088-A1 | GLYCINE TRANSPORTER-1 INHIBITORS | Amgen Inc. (US) | 2009-04-01 | — | — | EP | disclosed |
| US-20080269490-A1 | Chiral dipyridylphospine ligands bound to transition metal catalyst for catalysis of reactions under air atmosphere, normal atmosphere, mild temperatures without addition of organic or inorganic base; air-accelerated, copper(II) catalyzed asymmetric hydrosilylations reactions | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2008-10-30 | — | — | US | disclosed |
| US-20080249308-A1 | Complexes of Ruthenium with 2-(Aminomethyl)Pyridines and Phosphines, their Preparation and Use as Catalysts | UNIVERSITA'DEGLI STUDI DI UDINE (IT) | 2008-10-09 | — | — | US | disclosed |
| US-20080194669-A1 | T Type Calcium Channel Blockers and the Treatment of Diseases | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2008-08-14 | — | — | US | disclosed |
| EP-1747224-B1 | COMPLEXES OF RUTHENIUM WITH 2-(AMINOMETHYL)PYRIDINES AND PHOSPHINES, THEIR PREPARATION AND USE AS CATALYSTS | UNIV DEGLI STUDI UDINE (IT) | 2008-07-16 | — | — | EP | disclosed |
| EP-1778619-A4 | T TYPE CALCIUM CHANNEL INHIBITORS | UNIV VIRGINIA (US) | 2008-05-14 | — | — | EP | disclosed |
| EP-1727783-A4 | CHIRAL TERTIARY AMINOALKYLNAPHTHOLS | UNIV HONG KONG POLYTECHNIC (CN) | 2008-03-19 | — | — | EP | disclosed |
| US-20080045757-A1 | Chiral Tertiary Aminoalkylnaphthols | THE HONG KONG POLYTECHNIC UNIVERSITY (HK) | 2008-02-21 | — | — | US | disclosed |
| WO-2008002583-A1 | GLYCINE TRANSPORTER-1 INHIBITORS | AMGEN INC. (US) | 2008-01-03 | — | — | WO | disclosed |
| US-20080004289-A1 | Glycine transporter-1 inhibitors | AMGEN INC. | 2008-01-03 | — | — | US | disclosed |
| EP-1858644-A2 | METHOD FOR ASYMMETRIC HYDROSILYLATION OF KETONES | The Hong Kong Polytechnic University (CN) | 2007-11-28 | — | — | EP | disclosed |
| EP-1610792-B1 | CALCIUM CHANNEL BLOCKERS COMPRISING TWO BENZHYDRIL MOIETIES | NEUROMED TECH INC (CA) | 2007-10-10 | — | — | EP | disclosed |
| EP-1610792-B1 | CALCIUM CHANNEL BLOCKERS COMPRISING TWO BENZHYDRIL MOIETIES | NEUROMED TECH INC (CA) | 2007-10-10 | — | — | EP | disclosed |
| CN-1997641-A | Diarylamine derivatives as calcium channel blockers | NEUROMED PHARMACEUTICALS LTD (CA) | 2007-07-11 | — | — | CN | disclosed |
| EP-1778619-A2 | T TYPE CALCIUM CHANNEL INHIBITORS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2007-05-02 | — | — | EP | disclosed |
| EP-1778245-A2 | T TYPE CALCIUM CHANNEL BLOCKERS AND THE TREATMENT OF DISEASES | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2007-05-02 | — | — | EP | disclosed |
| EP-1745042-A1 | DIARYLAMINE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | Neuromed Pharmaceuticals, Ltd. (CA) | 2007-01-24 | — | — | EP | disclosed |
| EP-1727783-A1 | CHIRAL TERTIARY AMINOALKYLNAPHTHOLS | The Hong Kong Polytechnic University (CN) | 2006-12-06 | — | — | EP | disclosed |
| WO-2006089129-A2 | METHOD FOR ASYMMETRIC HYDROSILYLATION OF KETONES | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2006-08-24 | — | — | WO | disclosed |
| US-20060084660-A1 | Psychological disorders; analgesics; Parkinson's disease; antiepileptic agents; irritable bowel disorders; antiarrhythmia agents | NEUROMED TECHNOLOGIES INC. | 2006-04-20 | — | — | US | disclosed |
| US-20060084660-A1 | Psychological disorders; analgesics; Parkinson's disease; antiepileptic agents; irritable bowel disorders; antiarrhythmia agents | NEUROMED TECHNOLOGIES INC. | 2006-04-20 | — | — | US | disclosed |
| US-20060084660-A1 | Psychological disorders; analgesics; Parkinson's disease; antiepileptic agents; irritable bowel disorders; antiarrhythmia agents | NEUROMED TECHNOLOGIES INC. | 2006-04-20 | — | — | US | disclosed |
| EP-1461041-A4 | PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES | PHARMASSET LTD (BB) | 2006-03-29 | — | — | EP | disclosed |
| WO-2006023881-A2 | T TYPE CALCIUM CHANNEL BLOCKERS AND THE TREATMENT OF DISEASES | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2006-03-02 | — | — | WO | disclosed |
| WO-2006023883-A2 | T TYPE CALCIUM CHANNEL INHIBITORS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2006-03-02 | — | — | WO | disclosed |
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | disclosed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | disclosed |
| EP-1610792-A1 | CALCIUM CHANNEL BLOCKERS COMPRISING TWO BENZHYDRIL MOIETIES | Neuromed Technologies, Inc. (CA) | 2006-01-04 | — | — | EP | disclosed |
| WO-2005097779-A1 | DIARYLAMINE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | NEUROMED PHARMACEUTICALS LTD. (CA) | 2005-10-20 | — | — | WO | disclosed |
| US-20050227999-A1 | Diarylamine derivatives as calcium channel blockers | NEUROMED TECHNOLOGIES INC. | 2005-10-13 | — | — | US | disclosed |
| US-6951862-B2 | Calcium channel blockers comprising two benzhydril moieties | NEUROMED TECHNOLOGIES, INC. (CA) | 2005-10-04 | — | — | US | disclosed |
| US-6949554-B2 | Calcium channel blockers comprising two benzhydril moieties | NEUROMED TECHNOLOGIES INC. (CA) | 2005-09-27 | — | — | US | disclosed |
| WO-2005087707-A1 | CHIRAL TERTIARY AMINOALKYLNAPHTHOLS | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2005-09-22 | — | — | WO | disclosed |
| US-6946475-B1 | Phenyl substituted pyrrole and pyridine compounds as nontoxic antiproliferative agents. | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2005-09-20 | — | — | US | disclosed |
| CN-1620295-A | Preparation of intermediates for the synthesis of antiviral nucleosides | PHARMASSET LTD (BB) | 2005-05-25 | — | — | CN | disclosed |
| US-20050038072-A1 | Nitrogeneous cyclic ketone derivative, process for producing the same, and use | TAKEDA CHEMICAL INDUSTRIES, LTD. | 2005-02-17 | — | — | US | disclosed |
| US-20040259866-A1 | Calcium channel blockers comprising two benzhydril moieties | ZALICUS PHARMACEUTICALS LTD. (CA) | 2004-12-23 | — | — | US | disclosed |
| US-20040259866-A1 | Calcium channel blockers comprising two benzhydril moieties | ZALICUS PHARMACEUTICALS LTD. (CA) | 2004-12-23 | — | — | US | disclosed |
| US-20040259866-A1 | Calcium channel blockers comprising two benzhydril moieties | ZALICUS PHARMACEUTICALS LTD. (CA) | 2004-12-23 | — | — | US | disclosed |
| US-20040259912-A1 | Benzine derivatives, process for preparing the same and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-12-23 | — | — | US | disclosed |
| WO-2004089377-A1 | CALCIUM CHANNEL BLOCKERS COMPRISING TWO BENZHYDRIL MOIETIES | NEUROMED TECHNOLOGIES, INC. (CA) | 2004-10-21 | — | — | WO | disclosed |
| WO-2004089377-A1 | CALCIUM CHANNEL BLOCKERS COMPRISING TWO BENZHYDRIL MOIETIES | NEUROMED TECHNOLOGIES, INC. (CA) | 2004-10-21 | — | — | WO | disclosed |
| US-20040209872-A1 | Calcium channel blockers comprising two benzhydril moieties | ZALICUS PHARMACEUTICALS LTD. (CA) | 2004-10-21 | — | — | US | disclosed |
| US-20040209872-A1 | Calcium channel blockers comprising two benzhydril moieties | ZALICUS PHARMACEUTICALS LTD. (CA) | 2004-10-21 | — | — | US | disclosed |
| US-20040209872-A1 | Calcium channel blockers comprising two benzhydril moieties | ZALICUS PHARMACEUTICALS LTD. (CA) | 2004-10-21 | — | — | US | disclosed |
| EP-1461041-A2 | PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES | Pharmasset Ltd. (BB) | 2004-09-29 | — | — | EP | disclosed |
| EP-1460062-A1 | NITROGENOUS CYCLIC KETONE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE | Takeda Chemical Industries, Ltd. (JP) | 2004-09-22 | — | — | EP | disclosed |
| EP-1437344-A1 | BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2004-07-14 | — | — | EP | disclosed |
| EP-1165508-B1 | ANTICANCER CALCIUM CHANNEL BLOCKERS | THE UNIVERSITY OF VIRGINIA PAT (US) | 2004-06-23 | — | — | EP | disclosed |
| US-20040034035-A1 | Calcium channel inhibitors comprising benzhydril spaced from piperazine | NEUROMED TECHNOLOGIES, INC. | 2004-02-19 | — | — | US | disclosed |
| US-20030162992-A1 | Reacting a 2,2-dialkoxyethyl halide with an appropriate carboxylate compound to obtain acetal compound; hydrolyzing the acetal to form the alpha -acyloxyacetaldehyde | PHARMASSET, INC. | 2003-08-28 | — | — | US | disclosed |
| WO-2003051298-A2 | PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES | PHARMASSET LTD. (BB) | 2003-06-26 | — | — | WO | disclosed |
| US-20030023096-A1 | Naphthyloxy acetic acid derivatives and a pharmaceutical composition comprising them as an active ingredient | NAGAO YUUKI (JP) | 2003-01-30 | — | — | US | disclosed |
| US-6417213-B2 | ANTICOAGULANTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2002-07-09 | — | — | US | disclosed |
| US-20020006944-A1 | Tricyclic compounds, their production and use | OHKAWA SHIGENORI (JP) | 2002-01-17 | — | — | US | disclosed |
| EP-1165508-A1 | ANTICANCER CALCIUM CHANNEL BLOCKERS | Gray, Lloyd S. (US) | 2002-01-02 | — | — | EP | disclosed |
| US-6335366-B2 | A PROSTAGLANDIN E2 ANTAGONIST OR AGONIST WHICH COMPRISES A NAPHTHYLHYDROXY DERIVATIVES OR NAPHTHYLOXYALKYLENE DERIVATIVES OR NONTOXIC SALTS | ONO PHARMACEUTICAL CO., LTD. (JP) | 2002-01-01 | — | — | US | disclosed |
| WO-2000059882-A9 | ANTICANCER CALCIUM CHANNEL BLOCKERS | GRAY LLOYD S (US) | 2001-11-29 | — | — | WO | disclosed |
| US-20010005760-A1 | Naphthyloxy acetic acid derivatives and a pharmaceutical composition comprising them as an active ingredient | NAGAO YUUKI (JP) | 2001-06-28 | — | — | US | disclosed |
| US-6248766-B1 | CARDIOVASCULAR DISORDERS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-06-19 | — | — | US | disclosed |
| US-6197993-B1 | PROSTAGLANDIN E2 ANTAGONISTS OR AGONISTS | ONO PHARMACEUTICAL CO., LTD. (JP) | 2001-03-06 | — | — | US | disclosed |
| WO-2000059882-A1 | ANTICANCER CALCIUM CHANNEL BLOCKERS | GRAY LLOYD S (US) | 2000-10-12 | — | — | WO | disclosed |
| US-6054542-A | USING COORDINATION CATALYSTS | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 2000-04-25 | — | — | US | disclosed |
| US-6018068-A | 2-(5-(2-(2RS-HYDROXY-3-PHENOXYPROPYLTHIO)ETHYL)-1-NAPHTHYLOXY) -ACETIC ACID METHYL ESTER, AND OTHER COMPOUNDS OF GIVEN FORMULA; USE AS PROSTAGLANDIN E2 ANTAGONISTS OR AGONISTS | ONO PHARMACEUTICAL CO., LTD. (JP) | 2000-01-25 | — | — | US | disclosed |
| EP-0894794-A1 | Optical isomers of cloperastine | AESCULAPIUS FARMACEUTICI S.r.l. (IT) | 1999-02-03 | — | — | EP | disclosed |
| EP-0845451-A1 | NAPHTHYLOXYACETIC ACID DERIVATIVES AND DRUGS COMPRISING THE SAME AS ACTIVE INGREDIENTS | ONO PHARMACEUTICAL CO., LTD. (JP) | 1998-06-03 | — | — | EP | disclosed |
| EP-0669347-B1 | Ethylene polymer, and process for preparing the same | MITSUI PETROCHEMICAL IND (JP) | 1998-05-06 | — | — | EP | disclosed |
| EP-0668296-B1 | Ethylene polymer and process for preparing the same | MITSUI PETROCHEMICAL IND (JP) | 1998-05-06 | — | — | EP | disclosed |
| US-5731393-A | Ethylene polymer, process for preparing the same, solid titanium catalyst component for ethylene polymerization and ethylene polymerization catalyst | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1998-03-24 | — | — | US | disclosed |
| EP-0801048-A1 | Process for producing benzhydrols | K I CHEMICAL INDUSTRY CO., LTD. (JP) | 1997-10-15 | — | — | EP | disclosed |
| EP-0677076-B1 | DIARYL CARBINOL METATHESIS CATALYSTS | SHELL OIL CO (US) | 1997-04-16 | — | — | EP | disclosed |
| EP-0686635-A1 | Pyridylthiazolidinecarboxylic acid amide derivatives, their preparation and their therapeutic uses | Sankyo Company Limited (JP) | 1995-12-13 | — | — | EP | disclosed |
| US-5470851-A | Antihistamine, anticoagulants | SANKYO COMPANY, LIMITED (JP) | 1995-11-28 | — | — | US | disclosed |
| US-RE35072-E | Cardiotonic agents and antiarrhythmic agents | ORTHO PHARMACEUTICAL CORPORATION (US) | 1995-10-24 | — | — | US | disclosed |
| EP-0677076-A1 | DIARYL CARBINOL METATHESIS CATALYSTS. | SHELL OIL CO (US) | 1995-10-18 | — | — | EP | disclosed |
| EP-0425701-B1 | CATALYST COMPONENT FOR OLEFIN POLYMERIZATION | TONEN CORP (JP) | 1995-09-13 | — | — | EP | disclosed |
| EP-0425702-B1 | CATALYST COMPONENT FOR OLEFIN POLYMERIZATION | TONEN CORP (JP) | 1995-09-13 | — | — | EP | disclosed |
| EP-0669347-A1 | Ethylene polymer, process for preparing the same, solid titanium catalyst component for ethylene polymerization and ethylene polymerization catalyst | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1995-08-30 | — | — | EP | disclosed |
| EP-0668296-A1 | Ethylene polymer and process for preparing the same | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1995-08-23 | — | — | EP | disclosed |
| WO-1994015989-A1 | DIARYL CARBINOL METATHESIS CATALYSTS | SHELL OIL COMPANY (US) | 1994-07-21 | — | — | WO | disclosed |
| US-5321000-A | Benzhydryl compounds as herbicide antidotes | MONSANTO COMPANY (US) | 1994-06-14 | — | — | US | disclosed |
| EP-0334813-B1 | Agents for the protection of plants against diseases | CIBA GEIGY AG (CH) | 1994-02-02 | — | — | EP | disclosed |
| US-5276118-A | Metal complex | SHELL OIL COMPANY (US) | 1994-01-04 | — | — | US | disclosed |
| US-5252569-A | Cardiotonic, antiarrythmia agents | ORTHO PHARMACEUTICAL CORPORATION (US) | 1993-10-12 | — | — | US | disclosed |
| EP-0331511-B1 | 6-SUBSTITUTED PURINYL PIPERAZINE DERIVATIVES | ORTHO PHARMACEUTICAL CORPORATION (US) | 1993-07-28 | — | — | EP | disclosed |
| EP-0549364-A1 | Pyridylthiazolidinecarboxylic acid amide derivatives, their preparation and their therapeutic uses | Sankyo Company Limited (JP) | 1993-06-30 | — | — | EP | disclosed |
| EP-0124287-B1 | METHOD AND TEST COMPOSITION FOR DETERMINATION OF HYDROGEN PEROXIDE | Kyowa Medex Co. Ltd. (JP) | 1993-03-03 | — | — | EP | disclosed |
| US-5177043-A | α-olefin polymerization catalyst component | TONEN CHEMICAL CORPORATION (JP) | 1993-01-05 | — | — | US | disclosed |
| US-5164390-A | Cardiac disorders | ORTHO PHARMACEUTICAL CORPORATION (US) | 1992-11-17 | — | — | US | disclosed |
| US-5162537-A | To safen acetamide herbicids used to control grassy and broadleaf weeds in rice, sorghum and wheat | MONSANTO COMPANY (US) | 1992-11-10 | — | — | US | disclosed |
| US-5132261-A | Magnesium containing coordination catalyst, durability, storage stability | TONEN CORPORATION (JP) | 1992-07-21 | — | — | US | disclosed |
| US-5130283-A | Of metal oxide suppor type with high catalytic acitivity | TONEN CORPORATION (JP) | 1992-07-14 | — | — | US | disclosed |
| US-5114896-A | Reaction product of magnesium, halogenated hydrocarbon, alkoxy compound, titanium compound, halogen-containing alcohol and solid halogenated hydrocarbon | TONEN CORPORATION (JP) | 1992-05-19 | — | — | US | disclosed |
| EP-0458618-A1 | 6-Substituted purinyl piperazine derivatives | ORTHO PHARMACEUTICAL CORPORATION (US) | 1991-11-27 | — | — | EP | disclosed |
| EP-0273695-B1 | METHOD OF PRODUCTION OF CATALYST CARRIER FOR POLYMERIZATION OF OLEFIN | Tonen Corporation (JP) | 1991-11-13 | — | — | EP | disclosed |
| US-5061667-A | REDUCED POWDERING OF POLYMER DURING POLYMERIZATION | TOG NENRYO KOGYO KK (TONEN CORPORATION) (JP) | 1991-10-29 | — | — | US | disclosed |
| EP-0445302-A1 | PROCESS FOR PRODUCING POLY-$g(a)-OLEFIN | Tonen Corporation (JP) | 1991-09-11 | — | — | EP | disclosed |
| EP-0445303-A1 | PROCESS FOR PRODUCING POLY-$g(a)-OLEFIN | Tonen Corporation (JP) | 1991-09-11 | — | — | EP | disclosed |
| EP-0440813-A1 | METHOD OF PRODUCING CATALYST COMPONENT FOR OLEFIN POLYMERIZATION | Tonen Corporation (JP) | 1991-08-14 | — | — | EP | disclosed |
| EP-0439622-A1 | CATALYTIC COMPONENT FOR ALPHA-OLEFIN POLYMERIZATION | Tonen Corporation (JP) | 1991-08-07 | — | — | EP | disclosed |
| US-5021574-A | Cardiotonic agents, antiarrhythmia agents | ORTHO PHARMACEUTICAL CORPORATION (US) | 1991-06-04 | — | — | US | disclosed |
| EP-0425701-A1 | CATALYST COMPONENT FOR OLEFIN POLYMERIZATION | Tonen Corporation (JP) | 1991-05-08 | — | — | EP | disclosed |
| EP-0425702-A1 | CATALYST COMPONENT FOR OLEFIN POLYMERIZATION | Tonen Corporation (JP) | 1991-05-08 | — | — | EP | disclosed |
| US-5001127-A | 4-substituted pyrazolo[3,4-d]pyrimidine derivatives | ORTHO PHARMACEUTICAL CORPORATION (US) | 1991-03-19 | — | — | US | disclosed |
| EP-0173472-B1 | CATALYST COMPONENT FOR POLYMERIZATION OF OLEFINS | Tonen Corporation (JP) | 1990-12-19 | — | — | EP | disclosed |
| EP-0264169-B1 | PROCESS FOR PRODUCING ETHYLENE-PROPYLENE COPOLYMER RUBBER | Tonen Corporation (JP) | 1990-11-22 | — | — | EP | disclosed |
| US-4964893-A | REDUCING INJURY TO A CROP PLANT | MONSANTO COMPANY (US) | 1990-10-23 | — | — | US | disclosed |
| US-4960743-A | Method for production of catalyst carrier for polymerization of olefin | TOA NENRYO KOGYO K.K. (JP) | 1990-10-02 | — | — | US | disclosed |
| US-4959096-A | SUBSTITUTED ISONICOTINIC ACID ESTERS | CIBA-GEIGY CORPORATION (US) | 1990-09-25 | — | — | US | disclosed |
| US-4959427-A | COORDINATION CATALYST CONTAINING DIALKYLMAGNESIUM, STEREOREGULAR POLYMERIZATION OF PROPYLENE | TOA NENRYO KOGYO, K.K. (JP) | 1990-09-25 | — | — | US | disclosed |
| EP-0385491-A1 | Optically active isomer of cloperastine possessing antitussive activity, a process for its preparation and pharmaceutical compositions which contain it | MAGIS FARMACEUTICI S.p.A. (IT) | 1990-09-05 | — | — | EP | disclosed |
| US-4942148-A | COORDINATION CATALYLTS OF METAL OXIDE, ORGANOMAGNESIUM COMPOUNDS, AN ORGANOALUMINUM COMPOUND, A TITANIUM COMPOUND AND ELECTRON DONOR COMPOUND | TOA NENRYO KOGYO, K.K. (JP) | 1990-07-17 | — | — | US | disclosed |
| EP-0208524-B1 | CATALYST COMPONENT FOR OLEFIN POLYMERIZATION | Tonen Corporation (JP) | 1990-05-16 | — | — | EP | disclosed |
| US-4916058-A | CHROMOGENS | KYOWA MEDEX CO., LTD. (JP) | 1990-04-10 | — | — | US | disclosed |
| EP-0171200-B1 | CATALYST COMPONENT FOR POLYMERIZATION OF OLEFINS | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1990-03-14 | — | — | EP | disclosed |
| US-4885300-A | CARDIOTONIC AND ANTIARRHYTHMIA AGENTS | ORTHO PHARMACEUTICAL CORPORATION (US) | 1989-12-05 | — | — | US | disclosed |
| US-4876257-A | 6-Substituted purinyl piperazine derivatives useful as cardiotonic and antiarrhythmic agents | ORTHO PHARMACEUTICAL CORPORATION (US) | 1989-10-24 | — | — | US | disclosed |
| EP-0334813-A2 | Agents for the protection of plants against diseases | CIBA-GEIGY AG (CH) | 1989-09-27 | — | — | EP | disclosed |
| EP-0331511-A1 | 6-Substituted purinyl piperazine derivatives | ORTHO PHARMACEUTICAL CORPORATION (US) | 1989-09-06 | — | — | EP | disclosed |
| EP-0331510-A2 | 4-Substituted pyrazolo[3,4-d]pyrimidine derivatives | ORTHO PHARMACEUTICAL CORPORATION (US) | 1989-09-06 | — | — | EP | disclosed |
| EP-0319226-A2 | Method for production of catalyst carrier for polymerization of olefin | Tonen Corporation (JP) | 1989-06-07 | — | — | EP | disclosed |
| EP-0312314-A1 | Catalyst component for olefin polymerization | Tonen Corporation (JP) | 1989-04-19 | — | — | EP | disclosed |
| EP-0309140-A1 | Catalytic component for olefin polymerization | Tonen Corporation (JP) | 1989-03-29 | — | — | EP | disclosed |
| US-4814313-A | COORDINATION CATALYSTS | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1989-03-21 | — | — | US | disclosed |
| US-4814312-A | COORDINATION CATALYSTS | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1989-03-21 | — | — | US | disclosed |
| US-4814311-A | COORDINATION CATALYSTS | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1989-03-21 | — | — | US | disclosed |
| EP-0273694-A1 | Method for production of catalyst component for olefin polymerization | Tonen Corporation (JP) | 1988-07-06 | — | — | EP | disclosed |
| EP-0273695-A1 | Method of production of catalyst carrier for polymerization of olefin | Tonen Corporation (JP) | 1988-07-06 | — | — | EP | disclosed |
| EP-0264169-A1 | Process for producing ethylene-propylene copolymer rubber | Tonen Corporation (JP) | 1988-04-20 | — | — | EP | disclosed |
| US-4727049-A | COORDINATION CATALYST CONTAINING OXIDE, DIHYDROCARBYL MAGNESIUM, HALOGEN CONTAINING ALCOHOL, ELECTRON DONOR AND TITANIUM COMPOUND | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1988-02-23 | — | — | US | disclosed |
| US-4693990-A | Production of catalyst component for olefin polymerization | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1987-09-15 | — | — | US | disclosed |
| EP-0208524-A1 | Catalyst component for olefin polymerization | Tonen Corporation (JP) | 1987-01-14 | — | — | EP | disclosed |
| US-4613579-A | MAGNESIUM, TITANIUM, HALO-ALCOHOL | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1986-09-23 | — | — | US | disclosed |
| EP-0187034-A2 | Process for producing poly-1-butene | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1986-07-09 | — | — | EP | disclosed |
| EP-0171200-A2 | Catalyst component for polymerization of olefins | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1986-02-12 | — | — | EP | disclosed |
| EP-0097071-B1 | BENZHYDRYL SULFINYLACETAMIDE DERIVATIVES AND THEIR THERAPEUTICAL USE | LABORATOIRE L. LAFON Société anonyme dite: (FR) | 1985-08-28 | — | — | EP | disclosed |
| EP-0124287-A2 | Method and test composition for determination of hydrogen peroxide | Kyowa Medex Co. Ltd. (JP) | 1984-11-07 | — | — | EP | disclosed |
| EP-0097071-A1 | Benzhydryl sulfinylacetamide derivatives and their therapeutical use | LABORATOIRE L. LAFON Société anonyme dite: (FR) | 1983-12-28 | — | — | EP | disclosed |
| US-4138488-A | Diphenylmethyl picolinic acid derivatives and their use as anti-acne agents | SCHERING CORPORATION (US) | 1979-02-06 | — | — | US | disclosed |
| US-3968147-A | COORDINATION CATALYST | MONSANTO COMPANY (US) | 1976-07-06 | — | — | US | disclosed |
| US-3946083-A | LUBRICANTS, DIELECTRIC FLUIDS | TESSENDERLO CHEMIE S.A. (BE) | 1976-03-23 | — | — | US | disclosed |
| US-3946083-A | LUBRICANTS, DIELECTRIC FLUIDS | TESSENDERLO CHEMIE S.A. (BE) | 1976-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (29 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180147568-A1 | MAGNETICALLY SEPARABLE IRON-BASED HETEROGENEOUS CATALYSTS FOR DEHYDROGENATION OF ALCOHOLS AND AMINES | ADH1A, ADH1C, ADH5 | IDO1 243/4885TDO2 448/4885HPGD 67/4885 |
| US-20120264804-A1 | T TYPE CALCIUM CHANNEL BLOCKERS AND THE TREATMENT OF DISEASES | CACNA1H, CACNA1G, CACNA1I | IDO1 1991/4885TDO2 2019/4885HPGD 2015/4885 |
| US-20090227595-A1 | GLYCINE TRANSPORTER-1 INHIBITORS | SLC18A2, SLC7A11, SLC6A5 | IDO1 287/4885TDO2 660/4885HPGD 1343/4885 |
| US-20040209872-A1 | Calcium channel blockers comprising two benzhydril moieties | CACNA1C, CACNA1F, CACNA1D | IDO1 3425/4885TDO2 3799/4885HPGD 969/4885 |
| US-20220226310-A1 | Bio-Based Medicines and Methods of Increasing Patient Compliance | PAH, BPGM, TPMT | IDO1 3627/4885TDO2 1317/4885HPGD 133/4885 |
| US-20080249308-A1 | Complexes of Ruthenium with 2-(Aminomethyl)Pyridines and Phosphines, their Preparation and Use as Catalysts | ADH5, PDK2, PDK1 | IDO1 2748/4885TDO2 423/4885HPGD 1463/4885 |
| US-20080194669-A1 | T Type Calcium Channel Blockers and the Treatment of Diseases | CACNA1I, CACNA1H, CACNA1G | IDO1 1963/4885TDO2 907/4885HPGD 1256/4885 |
| US-20090234019-A1 | T Type Calcium Channel Inhibitors | CACNA1H, CACNA1I, CACNA1G | IDO1 2177/4885TDO2 1049/4885HPGD 2317/4885 |
| US-20060084660-A1 | Psychological disorders; analgesics; Parkinson's disease; antiepileptic agents; irritable bowel disorders; antiarrhythmia agents | CACNA1D, CACNA1E, CACNA1B | IDO1 384/4885TDO2 1307/4885HPGD 499/4885 |
| US-20040259866-A1 | Calcium channel blockers comprising two benzhydril moieties | CACNA1C, CACNA1F, CACNA1D | IDO1 3425/4885TDO2 3799/4885HPGD 969/4885 |
| US-20050227999-A1 | Diarylamine derivatives as calcium channel blockers | ORAI1, CACNA1D, CACNA1C | IDO1 1799/4885TDO2 3393/4885HPGD 999/4885 |
| US-10369120-B2 | T type calcium channel inhibitors | CACNA1H, CACNA1I, CACNA1G | IDO1 2177/4885TDO2 1049/4885HPGD 2317/4885 |
| US-20020006944-A1 | Tricyclic compounds, their production and use | CNR1, PTGER1, PTGDR | IDO1 966/4885TDO2 1112/4885HPGD 376/4885 |
| US-20080045757-A1 | Chiral Tertiary Aminoalkylnaphthols | ALDH7A1, ADH5, ALDH1A1 | IDO1 515/4885TDO2 268/4885HPGD 975/4885 |
| US-20120195985-A1 | GLYCINE TRANSPORTER-1 INHIBITORS | SLC18A2, SLC6A5, SLC1A2 | IDO1 303/4885TDO2 798/4885HPGD 1449/4885 |
| US-10335775-B2 | Magnetically separable iron-based heterogeneous catalysts for dehydrogenation of alcohols and amines | ADH1A, ADH1C, ADH5 | IDO1 243/4885TDO2 448/4885HPGD 67/4885 |
| US-20120088938-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | ADH1A, ADH1C, FHIT | IDO1 4327/4885TDO2 1885/4885HPGD 568/4885 |
| US-20010005760-A1 | Naphthyloxy acetic acid derivatives and a pharmaceutical composition comprising them as an active ingredient | CNR1, GIPR, HCAR1 | IDO1 1206/4885TDO2 618/4885HPGD 652/4885 |
| US-20160136115-A1 | T TYPE CALCIUM CHANNEL INHIBITORS | CACNA1H, CACNA1I, CACNA1G | IDO1 2177/4885TDO2 1049/4885HPGD 2317/4885 |
| US-20030023096-A1 | Naphthyloxy acetic acid derivatives and a pharmaceutical composition comprising them as an active ingredient | CNR1, HCAR1, GIPR | IDO1 870/4885TDO2 670/4885HPGD 577/4885 |
| US-20080004289-A1 | Glycine transporter-1 inhibitors | SLC18A2, SLC7A11, SLC6A5 | IDO1 287/4885TDO2 660/4885HPGD 1343/4885 |
| US-20050038072-A1 | Nitrogeneous cyclic ketone derivative, process for producing the same, and use | BDKRB1, BDKRB2, TACR1 | IDO1 1051/4885TDO2 649/4885HPGD 357/4885 |
| US-20100222406-A1 | T Type Calcium Channel Blockers and the Treatment of Diseases | CACNA1I, CACNA1H, CACNA1G | IDO1 1963/4885TDO2 907/4885HPGD 1256/4885 |
| US-20040034035-A1 | Calcium channel inhibitors comprising benzhydril spaced from piperazine | CACNA1C, CACNA1F, CACNA1D | IDO1 3991/4885TDO2 4490/4885HPGD 1436/4885 |
| US-20030162992-A1 | Reacting a 2,2-dialkoxyethyl halide with an appropriate carboxylate compound to obtain acetal compound; hydrolyzing the acetal to form the alpha -acyloxyacetaldehyde | DERA, DPYD, DHPS | IDO1 641/4885TDO2 283/4885HPGD 609/4885 |
| US-20150307457-A1 | GLYCINE TRANSPORTER-1 INHIBITORS | SLC18A2, SLC7A11, SLC6A5 | IDO1 287/4885TDO2 660/4885HPGD 1343/4885 |
| US-20040259912-A1 | Benzine derivatives, process for preparing the same and use thereof | HRH4, HRH2, HRH1 | IDO1 953/4885TDO2 675/4885HPGD 557/4885 |
| US-20080269490-A1 | Chiral dipyridylphospine ligands bound to transition metal catalyst for catalysis of reactions under air atmosphere, normal atmosphere, mild temperatures without addition of organic or inorganic base; air-accelerated, copper(II) catalyzed asymmetric hydrosilylations reactions | HRH3, HRH4, HRH1 | IDO1 153/4885TDO2 26/4885HPGD 3389/4885 |
| US-20160200768-A1 | VANCOMYCIN DERIVATIVE, AND PREPARATION METHOD AND APPLICATION THEREOF | LIPA, HDLBP, CETP | IDO1 2801/4885TDO2 2193/4885HPGD 1532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.